Rockville, Maryland — October 7, 2026 : New Fact.MR research shows the Health Economics and Outcomes Research Services market expanding from USD 2.8 billion in 2026 to USD 7.9 billion by 2036, advancing at a 10.9% CAGR during the forecast period. The market is gaining momentum as pharmaceutical sponsors and healthcare stakeholders require stronger economic evidence to support pricing, reimbursement, market access, and payer decisions.
Get detailed market forecasts, competitive benchmarking, and pricing trends:
Payer evidence requirements are emerging as a major growth catalyst. Increasing scrutiny of treatment value and budget impact is encouraging sponsors to plan health economics and outcomes research earlier in the product lifecycle. The report also identifies real-world evidence programs and digital evidence workflows as factors supporting demand, while data access limitations, model transparency concerns, and country-specific payer requirements remain important constraints.
Health Economics Studies lead the service offering, accounting for 39.0% of market share in 2026, as reimbursement decisions continue to require evidence around treatment value and affordability. Cost-effectiveness Analysis represents the leading application with a 36.0% share, reflecting its role in comparing therapy outcomes against healthcare costs. Pharmaceutical Companies hold 41.0% of end-user demand, while Project-based Services account for 48.0% of the delivery model and Decision Analytic Modeling captures 44.0% of the research methodology segment.
The USA is projected to register the fastest country-level growth at 11.8% CAGR through 2036, supported by extensive payer networks and the need for budget-impact evidence. Germany follows at 11.4%, where reimbursement assessments emphasize comparative evidence and economic reasoning. The UK is expected to grow at 10.9%, with sponsors requiring cost-effectiveness models aligned with national access and review expectations.
Unlock 360° insights for strategic decision making and investment planning:
The competitive landscape features IQVIA Holdings Inc., ICON plc, Syneos Health, Inc., Parexel International Corporation, and Cytel Inc., alongside RTI Health Solutions, Oracle Corporation, Costello Medical, and Axtria Inc. These providers compete through HEOR design, economic modeling, real-world evidence, and market-access capabilities.
With payer scrutiny increasing across major healthcare markets, HEOR services are becoming an increasingly central component of launch and reimbursement planning. The full Fact.MR report provides detailed market sizing, segment analysis, country-level forecasts, competitive intelligence, and strategic insights for stakeholders evaluating opportunities in the global HEOR services market.
Explore More Related Studies Published by Fact.MR Research
Non-Invasive Diagnostic Tests Market
Disposable Spirometry Filters Market
Dual-Chamber Cartridge Plungers Market
Elastomeric Pump Cartridges Market
CPAP Humidifier Chambers Market
About Fact.MR
Fact.MR is a market research and consulting firm providing syndicated research, customized research, investment research, and market intelligence across a broad range of industries. Its research coverage includes food and beverage, healthcare, pharmaceuticals, biotechnology, consumer products, chemicals and materials, technology, industrial goods, and packaging.
Fact.MR provides market intelligence designed to help organizations understand market dynamics, emerging opportunities, competitive developments, and changing industry requirements.
Media Contact
Fact.MR
Email: sales@factmr.com
Phone: +1 (628) 251-1583
Website: www.factmr.com
